Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Advent Clinical Research Centers
mi
from
Pinellas Park, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Advent Clinical Research Centers
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardio-Pulmonary Associates
mi
from
Plantation, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardio-Pulmonary Associates
mi
from
Plantation, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Avivo Clin Clinical Services
mi
from
Port Orange, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Avivo Clin Clinical Services
mi
from
Port Orange, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Heartcare Research
mi
from
Sarasota, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Heartcare Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
St. Augustine Cardiology Associates
mi
from
St. Augustine, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
St. Augustine Cardiology Associates
mi
from
St. Augustine, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Dr Kiran C Patel Research Institute At Pepin Heart Hospital
mi
from
Tampa, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Dr Kiran C Patel Research Institute At Pepin Heart Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Howard T. Tee, M.D., F.A.C.P., F.A.C.C.
mi
from
Vero Beach, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Howard T. Tee, M.D., F.A.C.P., F.A.C.C.
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Indian River Cardiovascular Associates, Inc
mi
from
Vero Beach, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Indian River Cardiovascular Associates, Inc
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardiology Partners Clinical Research Institute
mi
from
Wellington, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardiology Partners Clinical Research Institute
mi
from
Wellington, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardiovascular Physicians Of North Atlanta
mi
from
Atlanta, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardiovascular Physicians Of North Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Medical College of Georgia
mi
from
Augusta, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Columbus Cardiology Associates, PC
mi
from
Columbus, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Columbus Cardiology Associates, PC
mi
from
Columbus, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Georgia Heart Specialists
mi
from
Covington, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Georgia Heart Specialists
mi
from
Covington, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Atlanta Institute for Medical Research, Inc
mi
from
Decatur, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Atlanta Institute for Medical Research, Inc
mi
from
Decatur, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
In-Quest Medical Research, Llc
mi
from
Duluth, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
In-Quest Medical Research, Llc
mi
from
Duluth, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Alta Pharmaceutical Research Center
mi
from
Dunwoody, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Alta Pharmaceutical Research Center
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
North Georgia Medical Research
mi
from
Ellijay, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
North Georgia Medical Research
mi
from
Ellijay, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Northeast Georgia Heart Cntr, Pc
mi
from
Gainesville, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Northeast Georgia Heart Cntr, Pc
mi
from
Gainesville, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Mercer University School of Medicine
mi
from
Macon, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Mercer University School of Medicine
mi
from
Macon, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Well Star Cardiovascular Medicine, Pc
mi
from
Marietta, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Well Star Cardiovascular Medicine, Pc
mi
from
Marietta, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Southern Heart Research Institute
mi
from
Riverdale, GA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Southern Heart Research Institute
mi
from
Riverdale, GA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Memorial Hospital of Carbondale
mi
from
Carbondale, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Memorial Hospital of Carbondale
mi
from
Carbondale, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Northwestern University
mi
from
Chicago, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Rush University Medical Center
mi
from
Chicago, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
The University of Chicago Hospitals
mi
from
Chicago, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
The University of Chicago Hospitals
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Clinical Investigation Specialists, Inc.
mi
from
Gurnee, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Clinical Investigation Specialists, Inc.
mi
from
Gurnee, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Gateway Cardiology. P.C
mi
from
Jerseyville, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Gateway Cardiology. P.C
mi
from
Jerseyville, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Midwest Heart Foundation
mi
from
Lombard, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Midwest Heart Foundation
mi
from
Lombard, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Moline, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Moline, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Illinois Heart & Lung Research
mi
from
Normal, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Illinois Heart & Lung Research
mi
from
Normal, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
HeartCare Midwest
mi
from
Peoria, IL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
HeartCare Midwest
mi
from
Peoria, IL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
St Margaret Mercy Healthcare Centers
mi
from
Hammond, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
St Margaret Mercy Healthcare Centers
mi
from
Hammond, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Krannertt Institute Of Cardiology
mi
from
Indianapolis, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Krannertt Institute Of Cardiology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
R. L.Roudebush Va Medical Center
mi
from
Indianapolis, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
R. L.Roudebush Va Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
The Care Group, LLC
mi
from
Indianapolis, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
The Care Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Medical Consultants, P.C.
mi
from
Muncie, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Medical Consultants, P.C.
mi
from
Muncie, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Valparaiso, IN
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Valparaiso, IN
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
McFarland Clinic, PC
mi
from
Ames, IA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Midwest Cardiology Associates, P.C.
mi
from
Overland Park, KA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Midwest Cardiology Associates, P.C.
mi
from
Overland Park, KA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Kentucky Heart & Vascular Physicians
mi
from
Ashland, KY
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Kentucky Heart & Vascular Physicians
mi
from
Ashland, KY
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Hazard, KY
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Hazard, KY
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardiovascular Associates, Psc
mi
from
Louisville, KY
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardiovascular Associates, Psc
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Research Integrity, Llc
mi
from
Owensboro, KY
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Research Integrity, Llc
mi
from
Owensboro, KY
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Clinical Research Network
mi
from
Alexandria, LA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Clinical Research Network
mi
from
Alexandria, LA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Tulane University Hospital & Clinic
mi
from
New Orleans, LA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Tulane University Hospital & Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Overton Brooks VAMC
mi
from
Shreveport, LA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Overton Brooks VAMC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials